Expression of Bone Morphogenetic Proteins In Multiple Sclerosis Lesions.

Expression of Bone Morphogenetic Proteins In Multiple Sclerosis Lesions. Am J Pathol. 2018 Dec 13;: Authors: Costa C, Eixarch H, Martínez-Sáez E, Calvo-Barreiro L, Calucho M, Castro Z, Ortega-Aznar A, Ramón Y Cajal S, Montalban X, Espejo C Abstract Bone morphogenetic proteins (BMPs) are secreted proteins that belong to the transforming growth factor-beta superfamily. In the adult brain, they modulate neurogenesis, favor astrogliogenesis, and inhibit oligodendrogenesis. As BMPs may be involved in the failure of remyelination in multiple sclerosis (MS), we characterized the expression of BMP-2, -4, -5, and -7; BMP type II receptor (BMPRII); and phosphorylated (p)SMAD 1/5/8 in lesions of MS and other demyelinating diseases. Forty-two MS lesions, 12 acute ischemic lesions, eight progressive multifocal leucoencephalopathy lesions, and 10 CNS areas from four non-neuropathological patients were included. Lesions were histologically classified according to the inflammatory activity. The expression of BMP-2, BMP-4, BMP-5, BMP-7, BMPRII, and pSMAD1/5/8 was quantified by immunostaining, and colocalization studies were performed. In MS lesions, astrocytes, microglia/macrophages, and neurons expressed BMP-2, -4, -5, and -7; BMPRII; and pSMAD1/5/8, whereas oligodendrocytes expressed BMP-2 and -7 and pSMAD1/5/8. The percentage of cells that expressed BMPs, BMPRII, and pSMAD1/5/8 correlated with the inflammatory activity of MS lesions, and changes i...
Source: The American Journal of Pathology - Category: Pathology Authors: Tags: Am J Pathol Source Type: research

Related Links:

Ming Lu, Bennet J. McComish, Kathryn P. Burdon, Bruce V. Taylor, Heinrich K örner
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
We report here the findings of our study of the CNS demyelination process using immune-induced [experimental autoimmune encephalomyelitis (EAE)] and chemical-induced [cuprizone (CPZ)] mouse models of demyelination. We found that necroptosis, a receptor-interacting protein 3...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Biological Sciences Source Type: research
We present a multi-atlas segmentation technique based on white-matter-nulled MP-RAGE imaging that segments the thalamus into 12 nuclei with computation times on the order of 10 min on a desktop PC; we call this method THOMAS (THalamus Optimized Multi Atlas Segmentation). THOMAS was rigorously evaluated on 7T MRI data acquired from healthy volunteers and patients with multiple sclerosis by comparing against manual segmentations delineated by a neuroradiologist, guided by the Morel atlas. Segmentation accuracy was very high, with uniformly high Dice indices: at least 0.85 for large nuclei like the pulvinar and mediodorsal ...
Source: NeuroImage - Category: Neuroscience Source Type: research
Condition:   Multiple Sclerosis Intervention:   Other: Routine assessments Sponsor:   Dokuz Eylul University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Multiple Sclerosis Intervention:   Behavioral: Exergaming Sponsor:   Dokuz Eylul University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Multiple Sclerosis Intervention:   Other: Routine assessments Sponsor:   Dokuz Eylul University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Multiple Sclerosis Intervention:   Behavioral: Exergaming Sponsor:   Dokuz Eylul University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
(University of British Columbia) Researchers from the University of British Columbia and Vancouver Coastal Health Research Institute have found that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
This cohort study investigates whether the risk of reaching disability milestones of multiple sclerosis has changed over the last decade in Sweden.
Source: JAMA Neurology - Category: Neurology Source Type: research
ConclusionCommon benign MS definitions seem to simplify a complex disease picture where different impairments and personal resources lead to more or less impact on people ’s lives.
Source: Brain and Behavior - Category: Neurology Authors: Tags: ORIGINAL RESEARCH Source Type: research
More News: Brain | Multiple Sclerosis | Neurology | Neuroscience | Pathology | Science | Study